Loading...

STIM NEURONETICS INC US FDA Inspections 8-K Filing

NRNT

STM

NEURONETICS INC

(STIM)

2024 8-K

Financial Results Report

Management Changes

Management Change

Registration Rights Amendment

Executive Bonuses Approved

Financial Update

Credit Agreement Amendment

Executive Compensation Changes

Management Change

Debt-Equity Swaps

Financial Update

Financial Results

Management Changes

Acquisition Update

Financial Results

Acquisition Completed

Cash Flow Update

Nasdaq Compliance

Stockholder Approvals

Workforce Reduction

Financial Results

Registration Rights Amendment

Nasdaq Deficiency Notice

Proposed Arrangement

Acquisition Announcement

Conference Presentation

Acquisition Agreement

Merger Announcement

Acquisition Announcement

Credit Agreement and Guaranty

Presentation at Investor Co...

Annual Meeting of Stockholders

Financial Results Announcement

Investor Meetings

Management Changes

Supplemental Information on...

Compensation Awards

Earnings Report

Investor Conferences

Financial Results

Financial Results Announcement

Investor Conferences

Loan Agreement Amendment

Financial Results Announcement

Investor Conferences

Annual Meeting Results

Financial Results Announcement

Investor Conferences

Loan Agreement Amendment

Reaffirmation of Funding Es...

Investor Conferences

Financial Results Announcement

Compensation Awards

Earnings Reports

External Links:

Neuronetics, Inc. posted supplemental information about FDA clearance for NeuroStar Advanced Therapy for treating major depressive disorder in adolescent patients.

AI Assistant

NEURONETICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.